Gregory, John W.  ORCID: https://orcid.org/0000-0001-5189-3812, Townson, Julia ORCID: https://orcid.org/0000-0001-8679-3619, Channon, Sue ORCID: https://orcid.org/0000-0002-5394-1483, Cohen, David, Longo, Mirella ORCID: https://orcid.org/0000-0002-9867-3806, Davies, Justin, Nicola, Harman, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Pickles, Timothy ORCID: https://orcid.org/0000-0001-7743-0234, Playle, Rebecca ORCID: https://orcid.org/0000-0002-2989-1092, Tabitha, Randell, Robling, Michael ORCID: https://orcid.org/0000-0002-1004-036X, Morro, Touray, Trevelyan, Nicola, Warner, Justin and Lowes, Lesley ORCID: https://orcid.org/0000-0003-4452-217X
2019.
Effectiveness of home or hospital initiation of treatment at diagnosis for children with type 1 diabetes (DECIDE trial): a multicentre individually randomised controlled trial.
BMJ Open
9
, e032317.
10.1136/bmjopen-2019-032317
|
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution Non-commercial. Download (609kB) | Preview |
Abstract
Objective: To determine whether, in children with newly diagnosed type 1 diabetes who were not acutely unwell, management at home for initiation of insulin treatment and education of the child and family, would result in improved clinical and psychological outcomes at 2 years postdiagnosis. Design: A multicentre randomised controlled trial (January 2008/October 2013). Setting: Eight paediatric diabetes centres in England, Wales and Northern Ireland. Participants: 203 clinically well children aged under 17 years, with newly diagnosed type 1 diabetes and their carers. Intervention: Management of the initiation period from diagnosis at home, for a minimum of 3 days, to include at least six supervised injections and delivery of pragmatic educational care. Main outcome measures: Primary outcome was glycosylated haemoglobin (HbA1c) concentration at 24 months postdiagnosis. Secondary outcomes included coping, anxiety, quality of life and use of NHS resources. Results: 203 children, newly diagnosed, were randomised to commence management at home (n=101) or in hospital (n=102). At the 24 month primary end point, there was one withdrawal and a follow-up rate of 194/202 (96%). Mean HbA1c in the home treatment arm was 72.1 mmol/mol and in the hospital treated arm 72.6 mmol/mol. There was a negligible difference between the mean HbA1c levels in the two arms adjusted for baseline (1.01, 95% CI 0.93 to 1.09). There were mostly no differences in secondary outcomes at 24 months, apart from better child self-esteem in the home-arm. No home-arm children were admitted to hospital during initiation and there were no adverse events at that time. The number of investigations was higher in hospital patients during the follow-up period. There were no differences in insulin regimens between the two arms. Conclusions: There is no evidence of a difference between home-based and hospital-based initiation of care in children newly diagnosed with type 1 diabetes across relevant outcomes.
| Item Type: | Article |
|---|---|
| Date Type: | Publication |
| Status: | Published |
| Schools: | Schools > Medicine Research Institutes & Centres > Centre for Trials Research (CNTRR) |
| Additional Information: | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. |
| Publisher: | BMJ Publishing Group |
| ISSN: | 2044-6055 |
| Date of First Compliant Deposit: | 4 November 2019 |
| Date of Acceptance: | 4 November 2019 |
| Last Modified: | 23 Feb 2024 03:44 |
| URI: | https://orca.cardiff.ac.uk/id/eprint/126566 |
Citation Data
Cited 7 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
 |
Edit Item |
Altmetric
Altmetric